Where is Moroxite located?

Moroxite is headquartered in Lund, Sweden.

Is Moroxite a funded company?

Moroxite is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Feb 16, 2022.

When was the latest funding round of Moroxite?

Moroxite's latest funding was a $***** Seed round on Feb 16, 2022, with participation from 1 investor.

Where does Moroxite rank among its competitors?

Moroxite ranks 27th amongst 46 active competitors, of which 7 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Ruanxin, which secured $14.7M in Apr, 2026.

Who are the top competitors of Moroxite?

Moroxite's top competitors include Kuros Biosciences, ISTO Biologics and BONESUPPORT. Among them, Ruanxin secured the most recent funding round in April, 2026.

Moroxite - 2026 Company Profile, Funding & Competitors

Moroxite is a seed company based in Lund (Sweden). It operates as a Manufacturer of advanced biomaterials for spinal fusion and fracture fixation. Moroxite has raised an undisclosed amount in funding. The company has 46 active competitors, including 7 funded and 4 that have exited. Its top competitors include companies like Kuros Biosciences, ISTO Biologics and BONESUPPORT.

Company Details

Manufacturer of advanced biomaterials for spinal fusion and fracture fixation. The organization develops bone mineral granules and injectable bone substitutes designed to improve surgical outcomes. These products function as graft extenders and fixation tools to support healing in patients requiring orthopaedic intervention. The technology targets the integration of implants with bone tissue to reduce the likelihood of mechanical failure and the necessity for repeat procedures. Research efforts focus on the development of therapeutic carriers that facilitate bone regeneration and repair in various clinical applications.

Key Metrics

Location

Lund, Sweden

Stage

Seed

Latest Funding Round

Seed, Feb 16, 2022, $*****

Investors

Almi & 1 more

Ranked

27^th among 46 active competitors

Similar Companies

Kuros Biosciences & 46 more

View Moroxite's full profile

Moroxite has raised funding over 1 round. Its latest funding round was a Seed round on Feb 16, 2022 for $*****. 1 investor participated in its latest round. Moroxite has 2 institutional investors.

Here is the list of recent funding rounds of Moroxite:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 16, 2022	3470349	Seed	4027865	3142450	7235326	6073025

Access funding benchmarks and valuations. Sign up today!

View details of Moroxite's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Moroxite include Kuros Biosciences, ISTO Biologics and BONESUPPORT. Here is the list of Top 10 competitors of Moroxite, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Kuros Biosciences 2000, Schlieren (Switzerland), Public	Provider of smart solutions for bone disease management	$24.6M	Renaissance, NeoMed & 12 others	63/100
2nd	ISTO Biologics 1997, St. Louis (United States), Acquired	Developer of treatments for cartilage and bone problems	$40.7M	Keensight Capital, Life Sciences Partners ... & 8 others	62/100
3rd	BONESUPPORT 2000, Lund (Sweden), Public	Injectable, synthetic bone substitutes for remodeling	$101M	Tellacq Partners, Kreos Capital & 15 others	61/100
4th	OssDsign 2011, Uppsala (Sweden), Public	Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma	$19.7M	SEB, Eiffel Investment Group & 11 others	61/100
5th	Locate Bio 2001, Nottingham (United Kingdom), Series A	Developer next generation of orthobiologics products for the treatment of injuries	$31.6M	Mercia, BGF & 19 others	44/100
6th	Tetrous 2019, Sherman Oaks (United States), Series A	Manufacturer of demineralized bone fiber implants for surgical enthesis repair	$8.69M	-	43/100
7th	Askel Healthcare 2017, Helsinki (Finland), Funding Raised	Developer of regenerative medicines for cartilage & bone tissue regeneration	-	EIC Fund, Dualcore & 2 others	40/100
8th	Ventris Medical 2017, Newport Beach (United States), Unfunded	Provider of biologics and tissue healing products for orthopedic surgeons	-	-	34/100
9th	Renovos 2017, Southampton (United Kingdom), Series A	Provider of regenerative medicine solutions	$915K	Henley Business Angels, Orthopaedic Research ... & 19 others	33/100
10th	Ruanxin 2017, Shanghai (China), Seed	Developer of tissue engineered bone and cartilage for medical applications	$14.7M	Ruili Investment, Nuoyu Capital	29/100
27th	Moroxite Lund (Sweden), Seed	Manufacturer of advanced biomaterials for spinal fusion and fracture fixation	-	Almi, Fsg	20/100